Send us Feedback

Elan Corporation (ELN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ELN » Topics » DUBLIN, Ireland – December 16, 2008

This excerpt taken from the ELN 6-K filed Dec 16, 2008.
DUBLIN, Ireland – December 16, 2008 – Elan Corporation, plc (NYSE: ELN) today announced that it will present at the 27th Annual JP Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2009 at 11:30 a.m. PST, 2:30 p.m. EST, 7:30 p.m. GMT.  The presentation will be followed by a Q&A session.

Interested parties may access a live audio web cast of the presentation and Q&A session by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.  Following the live webcast, an archived version of the presentation and Q&A session will be available at the same URL.

About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

Source: Elan Corporation, plc
###
This excerpt taken from the ELN 6-K filed Oct 28, 2008.
DUBLIN, Ireland – October 28, 2008 – Elan Corporation, plc (NYSE: ELN) today announced that it will present at the 2008 DB-Biotech Boston Confab in Boston, Massachusetts on Tuesday, November 11, 2008 at 8:30 a.m. EST, 1:30 p.m. GMT.

Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.  Following the live webcast, an archived version of the call will be available at the same URL.

About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

Source: Elan Corporation, plc
###
 
 
 

This excerpt taken from the ELN 6-K filed Oct 14, 2008.
DUBLIN, Ireland – September 30, 2008 – Elan Corporation, plc (NYSE: ELN) today announced the dates for the following upcoming corporate events:

Third Quarter 2008 Financial Results

Elan will host a conference call on Thursday, October 23, 2008 at 8:30 a.m. Eastern Daylight Time (EDT), 1:30 p.m. British Summer Time (BST), with the investment community to discuss Elan's third quarter 2008 financial results, which will be released before U.S. and European financial markets open.

Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.  Following the live webcast, an archived version of the call will be available at the same URL.

Natixis Bleichroeder Hidden Gems Conference

Elan will present at the Natixis Bleichroeder Second Annual Hidden Gems Conference on Monday, October 13, 2008 at 11:00 am EDT, 4:00pm BST.  The conference takes place at the Waldorf Astoria in New York City.

Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.  Following the live webcast, an archived version of the call will be available at the same URL.

About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

Source: Elan Corporation, plc
###
 
 
 

This excerpt taken from the ELN 6-K filed Sep 30, 2008.
DUBLIN, Ireland – September 30, 2008 – Elan Corporation, plc (NYSE: ELN) today announced the dates for the following upcoming corporate events:

Third Quarter 2008 Financial Results

Elan will host a conference call on Thursday, October 23, 2008 at 8:30 a.m. Eastern Daylight Time (EDT), 1:30 p.m. British Summer Time (BST), with the investment community to discuss Elan's third quarter 2008 financial results, which will be released before U.S. and European financial markets open.

Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.  Following the live webcast, an archived version of the call will be available at the same URL.

Natixis Bleichroeder Hidden Gems Conference

Elan will present at the Natixis Bleichroeder Second Annual Hidden Gems Conference on Monday, October 13, 2008 at 11:30 am EDT, 4:30pm BST.  The conference takes place at the Waldorf Astoria in New York City.

Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.  Following the live webcast, an archived version of the call will be available at the same URL.

About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

Source: Elan Corporation, plc
###
 
 

This excerpt taken from the ELN 6-K filed Jun 5, 2008.
DUBLIN, Ireland – June 5, 2008 – Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Goldman Sachs 29th Annual Global Healthcare Conference on Wednesday, June 11, 2008 at 8:40 am PDT.  The conference takes place at the Ritz-Carlton Laguna Niguel in Dana Point, California. Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.

About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

Source: Elan Corporation, plc
###
 
 
 

This excerpt taken from the ELN 6-K filed May 22, 2008.
DUBLIN, Ireland – May 22, 2008 – Elan Corporation, plc (NYSE: ELN) today announced the appointments of Mr. Patrick Kennedy and Mr. Donal O’Connor, and the retirement of Mr. Laurence Crowley, as non-executive directors of the company, effective as of May 22, 2008.

Mr. Kyran McLaughlin, Chairman of Elan, said, “We are delighted to welcome Mr. Kennedy and Mr. O’Connor to the Board of Elan.  Their experience and enthusiasm for the Company and its objectives will add greatly to the operations of our Board.”

Mr. McLaughlin continued, “On behalf of the full Board of Directors, we also would like to thank Mr. Crowley for his outstanding contributions and dedicated service as a member of the Board over the past 12 years.  We wish him all the best in his future endeavors.”

Board Appointments:

Mr. Patrick Kennedy (39) is Chief Executive of Paddy Power plc, an international betting and gaming group listed on both the London and Irish Stock Exchanges.  Mr. Kennedy was previously Chief Financial Officer of Greencore Group plc and prior to that worked with McKinsey & Company and KPMG.  Mr. Kennedy is a graduate of University College Dublin and a Fellow of the Institute of Chartered Accountants in Ireland.

Mr. Donal O’Connor (57) was a Senior Partner of PricewaterhouseCoopers in Ireland from 1995 until 2007. He is a member of the PricewaterhouseCoopers Global Board and a former Chairman of the Eurofirms Board.  He is chairman of the Dublin Docks Development Authority, a member of the board of the Irish Auditing and Accounting Supervisory Authority and the Administrator of Icarom plc.  He is a graduate of University College Dublin and a Fellow of the Institute of Chartered Accountants in Ireland.

About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

Source: Elan Corporation, plc
###
 
 

This excerpt taken from the ELN 6-K filed Apr 18, 2008.
DUBLIN, Ireland – April 18, 2008 – Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 1, 2008 at 11:20am EDT in Miami, Florida. Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.

In addition, Elan will hold a Company Day on Wednesday May 7, 2008, beginning at 8am EDT and ending around 12pm EDT. The event will include strategic overviews of Research, Development, Commercial and Elan Drug Technology activities. Interested parties may access a live audio web cast of the event by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon.

About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

Source: Elan Corporation, plc
###

 

This excerpt taken from the ELN 6-K filed Mar 31, 2008.
DUBLIN, Ireland – March 31, 2008 – Elan Corporation, plc (NYSE: ELN) today announced the dates for upcoming corporate events and the publication and filing of its Annual Report for the fiscal year ended December 31, 2007.

Events

First Quarter 2008 Financial Results

Elan will report its first quarter 2008 financial results on April 24, 2008, before U.S. and European financial markets open.  The results announcement will be followed by a conference call at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST), with the investment community to discuss Elan’s first quarter 2008 financial results. Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to investors, members of the news media and the general public.  This event will be webcast live at www.elan.com and can be accessed by going to the Investor Relations section, then on the event icon. Following the live webcast, an archived version of the call will be available at the same URL.

Annual General Meeting (AGM)

Elan will hold its AGM at 10:00 a.m. BST on May 22, 2008 at the Shelbourne Hotel, Dublin 2, Ireland.  This event will also be webcast live and can be accessed by going to the Investor Relations section on Elan’s website at www.elan.com. Elan announced that Mr. Laurence Crowley will not seek re-election as a Director at the AGM and will retire on that date.

Filing of Annual Report

Elan has published its Annual Report for the year ended December 31, 2007, Notice of the 2008 AGM and Form of Proxy for use at the AGM. The Annual Report, Notice of the 2008 AGM along with Elan’s Form 20-F for the year ended December 31, 2007 (as filed with the Securities and Exchange Commission on February 28, 2008) are available on Elan’s website at www.elan.com. Elan will provide to all holders of Elan securities, upon request and free of charge, a hard copy of our complete audited financial statements included in our Form 20-F and Annual Report for the year ended December 31, 2007. A copy of the Annual Report and Notice of the AGM are being
 
1

 
 
 

 
FINAL - March 31, 2008
 
 
submitted to the Irish Stock Exchange and the UK Listing Authority, and will shortly be available for inspection at the following locations.

1.
Company Announcements Office,
 
Irish Stock Exchange,
 
28 Anglesea Street,
 
Dublin 2,
 
Ireland

2.
Document Viewing Facility,
 
Financial Services Authority,
 
25 The North colonnade,
 
Canary Wharf,
 
London E14 5HS
 
United Kingdom
   
About Elan
Elan Corporation, plc (NYSE: ELN) is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world.  Elan shares trade on the New York, London and Dublin Stock Exchanges.  For additional information about the company, please visit http://www.elan.com.

Source:  Elan Corporation, plc

###
 
 
 
 
 
 
 
 
 
 
 
 
2
This excerpt taken from the ELN 6-K filed Feb 4, 2008.
DUBLIN, Ireland – February 4, 2008 – Elan Corporation, plc (NYSE: ELN) announced today that Kelly Martin, President and CEO, has sold shares under a pre-arranged stock trading plan established in accordance with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.  The plan allows for the exercise of stock options for ordinary shares of Elan and the sale of those shares in a systematic manner. Mr. Martin adopted the plan in May 2006.  This was the first sale made under the plan.  Additional sales may occur in the future pursuant to the terms of the plan.

In addition, Dr. Lars Ekman, who retired as President of Research and Development on December 31, 2007, and who continues as an advisor and a member of the board of directors and chairman of the science & technology committee of the board, has also entered into a pre-arranged stock trading plan established in accordance with Rule 10b5-1.  Dr. Ekman’s plan allows for the exercise of stock options for ordinary shares of Elan and the sale of those shares in a systematic manner on up to six occasions between late February 2008 and December 31, 2009, at which date all of Dr. Ekman’s current options will expire.  The first sale of 125,000 Elan ordinary shares by Dr. Ekman is expected to occur in late February 2008.

SEC Rule 10b5-1 allows corporate executives to establish pre-arranged plans to sell a specified number of shares of company stock in accordance with a plan schedule.  These plans permit executives to change their investment portfolio gradually.  This minimizes the market effects of stock sales by spreading sales out over a more extended period of time rather than carrying out sales during limited trading windows following quarterly earnings announcements.  It also avoids concerns about initiating stock transactions while the executive may be aware of material nonpublic information.  Once a plan is established, the executive does not retain or exercise any discretion over sales of stock under the plan, and the pre-planned trades can be executed at later dates as set forth in the plan, without regard to any subsequent material nonpublic information that the executive might receive.

About Elan
 
Elan Corporation, plc (NYSE: ELN) is a neuroscience-based biotechnology company

 
-1-
 

committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world.  Elan shares trade on the New York, Londonand Dublin Stock Exchanges.  For additional information about the company, please visit http://www.elan.com.

Source:  Elan Corporation, plc
###
 
 
 
 
 
 
 
 
 
 
 
 
 
-2-

EXCERPTS ON THIS PAGE:

6-K
Dec 16, 2008
6-K
Oct 28, 2008
6-K
Oct 14, 2008
6-K
Sep 30, 2008
6-K
Jun 5, 2008
6-K
May 22, 2008
6-K
Apr 18, 2008
6-K
Mar 31, 2008
6-K
Feb 4, 2008
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki